Posted on 3/16/17
Specialty Pharmacy Times and Zitter Health Insights Announce Specialty Pharmacy Patient Choice Awards Finalists
CRANBURY, N.J.--(BUSINESS WIRE)--Specialty Pharmacy TimesĀ®, a full-service media resource dedicated to the business and practice of specialty pharmacy, and Zitter Health Insights (ZHI), which provides life . . .
Posted on 3/16/17
5 Things You Probably Didn't Know About Celgene Corporation
What comes to mind when you hear Celgene's (NASDAQ:CELG) name mentioned? Perhaps the biotech's blockbuster blood cancer drug Revlimid? Or maybe its fast-growing psoriasis drug Otezla?Celgene . . .
Posted on 3/16/17
Why Pacira Pharmaceuticals Stock Is Already Up 56% This Year
Pacira Pharmaceuticals'(NASDAQ:PCRX) Exparel is helping battle back against the opioid abuse crisis. A local anesthetic, the use of Exparel during surgery can reduce pain, and decrease . . .
Posted on 3/16/17
Will Pfizer's Growth Be Threatened by Novartis' New Cancer Drug?
Novartis (NYSE:NVS) announced on Monday that the U.S. Food and Drug Administration (FDA) approved Kisqali as a first-line treatment for hormone receptor positive, human epidermal growth . . .
Posted on 3/15/17
Celldex Therapeutics' (CLDX) CEO Anthony Marucci on Q4 2016 Results - Earnings Call Transcript
Celldex Therapeutics, Inc (NASDAQ:CLDX)Q4 2016 Earnings Conference CallMarch 14, 2017 16:30 ETExecutivesSarah Cavanaugh - Vice President, Investor Relations and Corporate CommunicationsAnthony Marucci - Co-Founder, President and . . .
Posted on 3/15/17
Celldex Therapeutics, Inc 2016 Q4 - Results - Earnings Call Slides
The following slide deck was published by Celldex Therapeutics, Inc in conjunction with their 2016 Q4 earnings call. 119READ FULL ARTICLE HERE
Posted on 3/15/17
Johnson & Johnson's (JNJ) Management Presents at Barclays Global Healthcare Conference 2017 (Transcript)
Johnson & Johnson (NYSE:JNJ)Barclays Global Healthcare Conference 2017March 14, 2017 08:30 AM ETExecutivesJennifer Taubert - Group Chairman, Pharmaceuticals, The AmericasJoseph Wolk - Vice President, Investor RelationsAnalystsGeoff . . .
Posted on 3/15/17
Johnson & Johnson: Be Wary Of Short-Term Thinking
Recently I was watching a financial broadcast where a guest said something peculiar. The program was focusing on a specific company and the guest suggested something . . .
Posted on 3/15/17
How a Major Drugmaker Plans to Cure Disease... Without Drugs
Pharmaceutical giant GlaxoSmithKline plc (NYSE:GSK) has the resources to pursue long-term bets in medicine that could eventually change the course of disease treatment and yield large . . .
Posted on 3/15/17
Novartis Takes Aim at Pfizer in Breast Cancer
Novartis (NYSE:NVS) has won a speedy approval for Kisqali, a new breast cancer drug that pits Novartis head-to-head against Pfizer's (NYSE:PFE) billion-dollar blockbuster drug Ibrance. It . . .
Posted on 3/15/17
AMO Pharma Enters into Collaboration Agreement with Ranedis Pharmaceuticals
AMO Pharma Limited, a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, today announced it has entered a collaboration agreement . . .
Posted on 3/15/17
U.S. News & World Report Names Children's Hospital of Philadelphia's Pediatrics Department Best in U.S. for 2018
U.S. News & World Report has recognized the Department of Pediatrics at Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of . . .
Posted on 3/15/17
Community Health Systems Announces Agreement to Divest Four Pennsylvania Hospitals
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE:CYH) announced today that subsidiaries of the Company have signed a definitive agreement to sell four Pennsylvania hospitals and their . . .
Posted on 3/14/17
Better Buy: Eli Lilly and Company vs. Pfizer
Two big pharma stocks posted nearly identical gains over the last 12 months. Eli Lilly's (NYSE:LLY) share price is up slightly under 15% during the period. . . .
Posted on 3/14/17
Valeritas Announces Reverse Stock Split
BRIDGEWATER, N.J., March 13, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) today announced that effective at 9:00 a.m., EDT, on March 15, 2017, the Company . . .
Posted on 3/14/17
Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that it has expanded its agreement with Astute Medical, Inc. for distribution of the . . .
Posted on 3/13/17
Wistar Research Teams Awarded More Than $4.7 Million in Funding
Scientists at The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, have secured more than $4,720,000 million in research funds. Ashani . . .
Posted on 3/13/17
The 3 Most Important Numbers for Johnson & Johnson
Your eyes would probably gloss over looking at all of the figures Johnson & Johnson(NYSE:JNJ) puts up. From adjusted earnings to Zyrtec sales, the healthcare giant . . .
Posted on 3/12/17
Fibrocell Announces One-for-Three Reverse Stock Split
EXTON, Pa., March 10, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective . . .
Posted on 3/10/17
Is Caladrius Biosciences Inc. A Buy?
Caladrius Biosciences Inc. (NASDAQ:CLBS), with its own contract manufacturing operation, presents a low-risk investment opportunity to enter the immunotherapy space, with the cost and risk of . . .
Posted on 3/10/17
Is Pacira Pharmaceuticals' Balance Sheet Safe?
Pacira Pharmaceuticals'(NASDAQ:PCRX) Exparel is tapping into growing demand for pain medications that can help reduce patient use of opioids following procedures. The shift away from opioids . . .
Posted on 3/10/17
5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade
What happens to Celgene (NASDAQ:CELG) after Revlimid runs its course?The big biotech projects strong growth through 2020, but much of its revenue will still come from . . .
Posted on 3/9/17
1 Thing About Pfizer, Inc. Stock That You Might Be Overlooking
There are several things about Pfizer (NYSE:PFE) stock for investors to like. Its dividend is a biggie. The potential for growth from products such as Ibrance . . .
Posted on 3/9/17
Select Medical And Dignity Health Form Joint Venture
Select Medical Corporation, a wholly-owned subsidiary of Select Medical Holdings Corporation (NYSE: SEM), today announced a joint venture agreement with Dignity Health to construct and operate . . .
Posted on 3/8/17
Pfizer's (PFE) Management Presents at Cowen and Company 37th Annual Healthcare Conference (Transcript)
Pfizer Inc. (NYSE:PFE)Cowen and Company 37th Annual Healthcare ConferenceMarch 07, 2017 11:20 AM ETExecutivesJohn Young - Group PresidentAnalystsSteve Scala - Cowen and CompanySteve Scala[Call Starts Abruptly] . . .

